Bulletin of the National Research Centre (Nov 2021)

Phylogenetic and full-length genome mutation analysis of SARS-CoV-2 in Indonesia prior to COVID-19 vaccination program in 2021

  • Reviany V. Nidom,
  • Setyarina Indrasari,
  • Irine Normalina,
  • Astria N. Nidom,
  • Balqis Afifah,
  • Lestari Dewi,
  • Andra K. Putra,
  • Arif N. M. Ansori,
  • Muhammad K. J. Kusala,
  • Mohammad Y. Alamudi,
  • Chairul A. Nidom

DOI
https://doi.org/10.1186/s42269-021-00657-0
Journal volume & issue
Vol. 45, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Background Indonesia has started the big project of COVID-19 vaccination program since 13 January 2021 by employing the first shot of vaccine to the President of Indonesia as the outbreak and rapid transmission of COVID-19 have endangered not only Indonesian but the global health and economy. This study aimed to investigate the full-length genome mutation analysis of 166 Indonesian SARS-CoV-2 isolates as of 12 January 2021. Results All data of the isolates were extracted from the Global Initiative on Sharing All Influenza Data (GISAID) EpiCoV database. CoVsurver platform was employed to investigate the full-length genome mutation analysis of all isolates. This study also focused on the phylogeny analysis in unlocking the mutation of S protein in Indonesian SARS-CoV-2 isolates. WIV04 isolate that was originated from Wuhan, China was used as the virus reference according to the CoVsurver default. The result showed that a full-length genome mutation analysis of 166 Indonesian SARS-CoV-2 isolates was successfully generated. Every single mutation in S protein was described and then visualized by utilizing BioRender platform. Furthermore, it also found that D614G mutation appeared in 103 Indonesian SARS-CoV-2 isolates. Conclusions To sum up, this study helped to observe the spread of COVID-19 transmission. However, it also proposed that the epidemiological surveillance and genomics studies might be improved on COVID-19 pandemic in Indonesia.

Keywords